• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany - results of a nationwide cross-sectional study].

作者信息

Fischer C, Mauss S, Zehnter E, Bokemeyer B, Heyne R, Hüppe D

机构信息

Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München.

出版信息

Z Gastroenterol. 2012 Jan;50(1):22-9. doi: 10.1055/s-0031-1281628. Epub 2012 Jan 5.

DOI:10.1055/s-0031-1281628
PMID:22222794
Abstract

BACKGROUND AND AIMS

Knowledge about the epidemiology, demography and social status of patients with replicative chronic hepatitis B (CHB) in Germany is still scarce. This cross-sectional study evaluated in patients with chronic hepatitis B infection, with a serum HBV-DNA concentration of at least 10,000 copies/mL (> 2000 IU/mL) at documentation visit, the epidemiology, socio-demographics, time of diagnosis, history of disease, prior therapies as well the therapeutic decision.

METHODS

74 German centres with predominately hepatologic focus, recorded in an online-survey the pseudonymised data of patients with chronic HBV-infection with a serum HBV-DNA-concentration of at least 10,000 copies/mL (n = 35).

RESULTS

65 % of the patients were male. The mean age was 40 ± 14 years. 63 % were immigrants (i. e., country of birth not being Germany). 37 % were HBeAg-positive. Mean ALT value 114 ± 183 IU/mL in males and 77 ± 176 IU/mL in females. ALT was above the upper limit of normal (ULN) in 59 % and 9 % of the patients were cirrhotic. The large immigrant groups, Turks (22 %), people from the former USSR (11 %) or from Southeast Asia (10 %) differed in terms of age, sex, HBeAg-status and clinical parameters clearly from each other as well as from German patients. 55 % of the patients from SE-Asia were female and overall considerably younger than German patients. 69 % of the patients with HBV-DNA > 10,000 copies/mL combined with ALT-levels above ULN, and 87 % with advanced fibrosis recieved antiviral treatment.

CONCLUSIONS

This database currently contains the largest collection of epidemiological data of CHB patients in Germany. It therefore allows a representative overview on the disease in Germany. In Germany CHB epidemiology is triggered by migration from countries with higher CHB prevalence. However, the high proportion of patients coming from states of the former USSR is likely to be a historical peculiarity of Germany. The sometimes weak German language skills as well as the cultural specifics in the different immigrant groups are still a challenge for health-care providers. The high proportion of viraemic patients, already being treated, could indicate a suboptimal efficacy of the available therapeutic options at the time documentation.

摘要

相似文献

1
[Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany - results of a nationwide cross-sectional study].
Z Gastroenterol. 2012 Jan;50(1):22-9. doi: 10.1055/s-0031-1281628. Epub 2012 Jan 5.
2
A survey of chronic hepatitis B patient management practices in the European Union.欧盟慢性乙型肝炎患者管理实践调查。
J Viral Hepat. 2010 Sep;17(9):624-30. doi: 10.1111/j.1365-2893.2010.01318.x. Epub 2010 May 4.
3
[Epidemiology of hepatitis B in Germany].[德国乙型肝炎流行病学]
Med Klin (Munich). 2007 May 15;102(5):351-7. doi: 10.1007/s00063-007-1033-4.
4
Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.慢性乙型肝炎:基于澳大利亚患者疾病自然史的治疗建议
J Clin Virol. 2005 Feb;32(2):122-7. doi: 10.1016/j.jcv.2004.10.009.
5
[Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].HBeAg阴性慢性乙型肝炎患者的血清谷丙转氨酶及乙肝病毒DNA水平
Taehan Kan Hakhoe Chi. 2003 Dec;9(4):284-92.
6
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.HBeAg阴性慢性乙型肝炎病毒感染自然病程中血清HBV DNA水平的纵向变化及疾病进展的预测因素
J Viral Hepat. 2008 Jun;15(6):434-41. doi: 10.1111/j.1365-2893.2007.00957.x. Epub 2008 Jan 9.
7
Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.急性乙型肝炎患者和慢性乙型肝炎急性发作患者的临床、生化、免疫和病毒学特征及鉴别诊断
J Gastroenterol Hepatol. 2008 Nov;23(11):1728-33. doi: 10.1111/j.1440-1746.2008.05600.x. Epub 2008 Sep 24.
8
Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.评估正常或轻度升高的丙氨酸转氨酶、年龄和 DNA 水平在预测慢性乙型肝炎肝组织学变化中的作用。
Liver Int. 2011 Jul;31(6):824-30. doi: 10.1111/j.1478-3231.2011.02491.x. Epub 2011 Mar 6.
9
Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.香港的乙型肝炎e抗原阴性慢性乙型肝炎
Hepatology. 2000 Mar;31(3):763-8. doi: 10.1002/hep.510310330.
10
Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B.乙型肝炎病毒载量增加与 HBeAg 阴性而非 HBeAg 阳性慢性乙型肝炎患者发生显著肝纤维化的风险相关。
Liver Int. 2010 Sep;30(8):1115-22. doi: 10.1111/j.1478-3231.2010.02267.x. Epub 2010 May 21.

引用本文的文献

1
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting.通过指南推荐在基层医疗环境中进行丁型肝炎筛查,成功修订现有的乙型肝炎筛查计划。
Aliment Pharmacol Ther. 2025 Feb;61(4):651-657. doi: 10.1111/apt.18424. Epub 2024 Dec 4.
2
[Epidemiology of viral hepatitis A to E in Germany].[德国甲型至戊型病毒性肝炎的流行病学]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):149-158. doi: 10.1007/s00103-021-03478-8. Epub 2022 Jan 14.
3
Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B.
基于 PAGE-B 风险评分指导的慢性乙型肝炎治疗后 HCC 监测的成本评估。
BMC Health Serv Res. 2021 Aug 21;21(1):846. doi: 10.1186/s12913-021-06794-6.
4
Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review.德国乙型、丙型和丁型肝炎的患病率:一项范围综述的结果
Front Public Health. 2020 Aug 28;8:424. doi: 10.3389/fpubh.2020.00424. eCollection 2020.
5
The epidemiology of Hepatitis B, C and D in Germany: A scoping review.德国乙型、丙型和丁型肝炎的流行病学:范围综述。
PLoS One. 2020 Mar 9;15(3):e0229166. doi: 10.1371/journal.pone.0229166. eCollection 2020.
6
Clinical management of chronic hepatitis B infection: results from a registry at a German tertiary referral center.慢性乙型肝炎感染的临床管理:德国一家三级转诊中心登记处的结果
Infection. 2015 Apr;43(2):153-62. doi: 10.1007/s15010-015-0751-4. Epub 2015 Feb 21.
7
Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.2014年慢性乙型肝炎:治疗取得重大进展,诊断存在巨大不足。
World J Gastroenterol. 2014 Sep 7;20(33):11595-617. doi: 10.3748/wjg.v20.i33.11595.
8
Disease burden of chronic hepatitis B among immigrants in Canada.加拿大移民中慢性乙型肝炎的疾病负担。
Can J Gastroenterol. 2013 Mar;27(3):137-47. doi: 10.1155/2013/924640.